WIN or Get Huge Savings!
|
The Real Difference between Vaginal and Cesarean births. Source: ScienceandSensiibility.org Date: 08/07/09
When a study compares one practice with another and reports “no difference” in outcomes, is that the end of the story? Not necessarily.
“No significant difference” can mean any of these:
• there really is no difference
• the study was too small to find the difference that really is there (it lacked “statistical power”)
• the outcome was measured or reported in a way that obscured a difference that really is there
• the
statistical test yielded a “false negative result,” failing to find a
difference that really is there (this type of error occurs in up to 1
out of 20 statistical results)
So in 3 out of
our 4 possibilities, the difference really is there, we just can’t see
it. How do we know when “no difference” means “no difference” and when
“no difference” means “keep looking”?
To understand
this problem, and how to best get around it, let’s have a look at
postpartum maternal morbidity after cesarean surgery versus vaginal
birth.
Perhaps you’ve
heard that there’s “no difference” in health outcomes between cesarean
surgery and vaginal birth. This is what women have been told ever since
a so-called “State-of-the-Science Conference” report was issued by the
National Institutes of Health in 2006. After evaluating the body of
literature comparing planned vaginal birth and planned cesarean section
in healthy women, the NIH reported, among other findings, that the
evidence that infection is more likely with planned cesarean is “weak”.
The report said that, although observational studies find a link
between cesarean and infection, the only randomized controlled trial
(RCT) of planned cesarean versus planned vaginal birth showed “no
significant difference” in infection rates.
It's basically 50/50, right?
In
contrast, a new population-based study from Denmark involving over
32,000 women giving birth between 2001 and 2005 reported that women who
gave birth by cesarean were nearly 5-times more likely than women who
gave birth vaginally to experience a wound infection, urinary tract
infection, or blood stream infection. Most of the difference was
attributed to wound infection, which occurred in 5.6% of women having
unscheduled cesareans in labor, 3.9% of women having scheduled
cesareans, and only 0.08% of women giving birth vaginally. In the
United States, where up to 500,000 cesareans may be safely preventable
each year, these data suggest that more than 20,000 postpartum wound
infections could be avoided annually along with the excess cesareans.
So what is the
disconnect between the “state of the science,” which tells us evidence
is “weak” and this new study, which paints a very different picture?
First, the NIH
conference, and the AHRQ-sponsored systematic review underpinning the
conference, compared planned routes of delivery while the Danish study
compared actual routes of delivery. The reviewers acknowledge that
studies comparing planned vaginal birth and planned elective cesarean
delivery in women with no pregnancy complications are scarce and
randomized controlled trials are absent. Rather than conduct a
systematic review without any randomized controlled trials, the
reviewers included was the Term Breech Trial (which I have previously
posted about), even though the results of the review would affect
recommendations made to women carrying head-down babies. But the Term
Breech Trial’s results are not applicable to women carrying head-down
babies, especially when infection is the outcome of interest. Why?
Because 57% of women randomized to give birth vaginally actually had
cesareans, and most of these presumably underwent the cesareans in
labor, which increases infection risk (along with risks of hemorrhage
and other complications). What’s more, breech vaginal births are much
more likely than vertex vaginal births to involve episiotomies,
instrumental delivery, or both, which increase the likelihood of
infection. So in the Term Breech Trial, the vaginal birth group
included far more women with cesareans, episiotomies, and instrumental
deliveries than we would expect to see in a similar group of women
planning vaginal birth of head-down babies. Despite these limitations
that make the trial useless for evaluating the true risks of infection
associated with each birth route, the AHRQ reviewers rated the Term
Breech Trial as the highest quality evidence comparing planned vaginal
with planned cesarean birth, trumping observational studies. In the
process, the message to women - and clinicians for that matter -
transformed from “Planning a cesarean is risky because you expose
yourself to excess infection risk” to something more like, “there could
be an excess risk of infection with cesarean, but it’s probably small
and, hey, for all we know there may be no real difference after all.”
Another reason
behind the disconnect is that the Term Breech Trial (again, the
“highest quality” evidence in the AHRQ review underpinning the NIH
conference) only measured infections occurring prior to hospital
discharge, a very common cut-off in both RCTs and observational
studies. The new Danish study provides striking evidence that this way
of measuring infection is grossly inadequate - more than three-quarters
(77%) of infections occurred after hospital discharge. In other words,
they would have been missed if the researchers had stopped counting the
number of infections as soon as the woman left the hospital. The
researchers were able to capture these infections because Denmark has a
national database of all births, which was linked to a national
database of all clinical laboratory results of infectious diseases, a
national database of all antibiotics prescribed, and a national
database of all hospital readmissions. (The United States, by the way,
has none of these, rendering this type of study literally impossible to
conduct here.) In randomized controlled trials, following participants
beyond the initial hospital stay is logistically difficult and very
costly. Even when follow-up is intended, substantial numbers of new
mothers may not respond to surveys or return (to the same
provider/facility or at all) for postpartum care. As a result, properly
constructed national databases provide an important source - sometimes
the only source - of evidence on long-term outcomes.
So which
“evidence” do we tell women? The “state of the science” or our less
rigid but almost certainly more reliable assessment of the
observational studies and our common sense? Of course cesarean can lead
to infection - it’s surgery after all. And yes, even with optimal care,
some women who plan vaginal births will need to have cesareans and some
of those women will get infections. If we’re serious about helping
women avoid serious complications like infections, we must:
• tell
women who intend to give birth vaginally how they can safely achieve
that, starting with the Lamaze Healthy Birth Practices
• help
women having vaginal births avoid practices that increase the risk of
perineal trauma and thus the risk of perineal infection, such as
episiotomy, instrumental delivery, and fundal pressure.
Women experience
many physical and mental health problems in the postpartum period, some
of which may be safely prevented with a different approach to care
given in pregnancy, labor, and birth or better education provided
prenatally. We do not know the factors contributing to postpartum
health problems because they are shamefully understudied. But one
treasure trove of postpartum data in the United States provides a
powerful foundation for addressing and researching postpartum health
outcomes. Childbirth Connection’s 2008 report, New Mothers Speak Out,
compiles the postpartum data and new mother testimonials from both the
2006 Listening to Mothers II Survey and a follow-up survey conducted
with participants six months later. All women’s health professionals
and advocates should spend time with this report so we can begin to
give postpartum concerns their due attention.
Citations:
Hannah ME, Hannah WJ, Hewson SA, Hodnett ED, Saigal S, & Willan AR
(2000). Planned caesarean section versus planned vaginal birth for
breech presentation at term: a randomised multicentre trial. Term
Breech Trial Collaborative Group. Lancet, 356 (9239), 1375-83 PMID:
11052579
Leth RA, Møller
JK, Thomsen RW, Uldbjerg N, & Nørgaard M (2009). Risk of selected
postpartum infections after cesarean section compared with vaginal
birth: A five-year cohort study of 32,468 women. Acta obstetricia et
gynecologica Scandinavica, 1-8 PMID: 19642043
Visco AG,
Viswanathan M, Lohr KN, Wechter ME, Gartlehner G, Wu JM, Palmieri R,
Funk MJ, Lux L, Swinson T, & Hartmann K (2006). Cesarean delivery
on maternal request: maternal and neonatal outcomes. Obstetrics and
gynecology, 108 (6), 1517-29 PMID: 17138788
Copyright 2007. All Rights Reserved. |
|
FREE Vitamix 5200 Contest!
|